Scarica l'app Stockscreener
62.55
4.93%
2.94
Dopo l'orario di chiusura:
62.10
-0.45
-0.72%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$59.61
Aprire:
$60.85
Volume 24 ore:
466.81K
Relative Volume:
0.64
Capitalizzazione di mercato:
$2.39B
Reddito:
-
Utile/perdita netta:
$-212.18M
Rapporto P/E:
-10.44
EPS:
-5.9897
Flusso di cassa netto:
$-181.33M
1 W Prestazione:
+5.77%
1M Prestazione:
-6.49%
6M Prestazione:
+0.08%
1 anno Prestazione:
+18.49%
Intervallo 1D:
$59.97
$63.18
Intervallo di 1 settimana:
$57.72
$63.18
Portata 52W:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
62.55 | 2.27B | 0 | -212.18M | -181.33M | -5.9897 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON - GlobeNewswire Inc.
Update Report: Will Disc Medicine Inc outperform during market ralliesGold Moves & Community Consensus Picks - baoquankhu1.vn
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Bluefield Daily Telegraph
Growth Review: Will Disc Medicine Inc outperform during market rallies2026 Technical Overview & Fast Gain Stock Trading Tips - baoquankhu1.vn
JPMorgan Chase & Co. Sells 90,737 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Hudson Bay Capital Management LP Acquires Shares of 102,185 Disc Medicine, Inc. $IRON - MarketBeat
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - Carroll County Mirror-Democrat
Disc Medicine targets dermatology growth with new bitopertin update at AAD conference - Traders Union
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Trade Recap: Is Disc Medicine Inc stock trending bullishDip Buying & Weekly Top Performers Watchlists - baoquankhu1.vn
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON - The Joplin Globe
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates - GlobeNewswire
Disc Medicine, Inc. (IRON) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - The Globe and Mail
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
First Light Asset Management LLC Acquires New Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Sees Large Growth in Short Interest - MarketBeat
Checkpoint Capital L.P. Acquires 165,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Atlas Venture Life Science Advisors LLC Has $141.58 Million Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Stake Trimmed by Victory Capital Management Inc. - MarketBeat
Is Disc Medicine (IRON) Pricing Attractive After Recent Pullback And DCF Valuation Gap - simplywall.st
IRON Investors Lose Up to $22/Share — LEVI & KORSINSKY, LLP Investigates Disc Medicine - Morningstar
Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals - Yahoo Finance
IRON: Phase III data for bitopertin and key pipeline readouts are expected by year-end - TradingView
Disc Medicine (IRON) Is Down 8.2% After Wider 2025 Loss and ESOP Shelf FilingHas The Bull Case Changed? - simplywall.st
Disc Medicine Stock Pre-Market (+9.8%): Sector Lift on J&J Hematology Approval - Trefis
Blue Owl Capital Holdings LP Sells 20,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Disc Medicine, Inc. $IRON Shares Acquired by Vanguard Group Inc. - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
William Jacob Savage Sells 7,378 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ: IRON) CMO sells 7,378 shares under 10b5-1 plan - Stock Titan
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst - AOL.com
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
IRON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IRON: Multiple late-stage programs advance toward pivotal data and regulatory milestones in 2024 - TradingView
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Update - MarketBeat
Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - ChartMill
IRON (NASDAQ: IRON) proposed insider sales including 13,093-share 12/15/2025 sale - Stock Titan
Watertown biotech cuts 20% of staff after FDA rejects rare disease drug - The Business Journals
IRON: Wells Fargo Raises Price Target for Disc Medicine | IRON S - GuruFocus
Disc Medicine (NASDAQ:IRON) Price Target Raised to $79.00 - MarketBeat
A Look At Disc Medicine (IRON) Valuation After Recent Share Price Swings - simplywall.st
Disc Medicine Refocuses On APOLLO Trial After FDA Letter For Bitopertin - Sahm
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf RegistrationWhat's Changed - Yahoo Finance
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):